After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Masimo and Apple (AAPL.O), opens new tab are engaged in a legal battle over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices ...

BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

Masimo and Apple are engaged in a legal battle over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices without the feature. Masimo ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie ...

Masimo MASI1.29%increase; green up pointing triangle appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of ...

Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2024 on Thursday. Following the robust preliminary results, the company’s shares gained nearly 0.1% ...

Masimo and Apple are engaged in a legal battle over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices without the feature.

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...